Skip to main content
. 2020 Apr 30;24(2):128–135. doi: 10.4103/ijem.IJEM_593_19

Table 2.

Available estrogen preparations in India

Estrogen preparations Dose Advantages Limitations
Oral Estradiol Valerate 2 to 8 mg per day Estradiol levels can be monitored, Risk of VTE is slightly less than with Ethinyl Estradiol or Conjugated Equine Estrogen High risk of VTE
Oral 17-beta Estradiol 1-6 mg daily Inexpensive and estradiol levels can be monitored High risk of VTE specially in older patients (>40 yrs )
Oral Ethinyl Estradiol 50-100 ug per day Inexpensive Cannot be monitored by measurement of serum levels and high risk of VTE
Conjugated Equine Estrogen 1.25 to 5 mg per day Widely available Cannot be monitored by measurement of serum levels, high risk of VTE, expensive and contains impurities
Parenteral Estradiol Valerate 10-20 mg IM every 1-2 week Estradiol levels can be monitored, Risk of VTE is slightly less than with Ethinyl Estradiol or Conjugated Equine Estrogen Injectable preparation
Transdermal 17-beta Estradiol gel (0.06%) for application 1.25 gm gel per day (0.75 mg estradiol) to 5 gm gel per day (3 mg estradiol) (Application in the arms or in the upper half of the body) Low risk of venous thromboembolism Not easily available in India May not be successful in a tropical country like India